Obesity, metabolic health, and the risk of end-stage renal disease

Kidney International

Volumn 87, Issue 6, 2015, Pages 1216-1222

  Panwar, Bhupesh ^a   Hanks, Lynae J ^a,b   Tanner, Rikki M ^b   Muntner, Paul ^a,b   Kramer, Holly ^c   McClellan, William M ^d   Warnock, David G ^a   Judd, Suzanne E ^b   Gutiérrez, Orlando M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

chronic kidney disease; inflammation; insulin resistance; lipids; nutrition; obesity

Indexed keywords

GLUCOSE;

ABNORMAL BLOOD PRESSURE; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; DEMOGRAPHY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH; HEMODIALYSIS; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC HEALTH; METABOLIC SYNDROME X; METABOLISM; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; AGED; BODY WEIGHT; COMPLICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OVERWEIGHT; UNITED STATES;

AGED; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; UNITED STATES;

EID: 84930275784     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.384     Document Type: Article

References (42)

1. Eckel RH, Kahn R, Robertson RM et al. Preventing cardiovascular disease and diabetes A call to action from the American Diabetes Association and the American Heart Association. Circulation 2006; 113: 2943-2946.
2. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
3. Foster MC, Hwang SJ, Larson MG et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008; 52: 39-48.
4. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
5. Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487.
6. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702.
7. Kramer H, Luke A, Bidani A et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 2005; 46: 587-594.
8. Gelber RP, Kurth T, Kausz AT et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46: 871-880.
9. Grubbs V, Lin F, Vittinghoff E et al. Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (coronary artery risk development in young adults) study. Am J Kidney Dis 2014; 63: 590-597.
10. Beddhu S, Pappas LM, Ramkumar N et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372.
11. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554.
12. Kalantar-Zadeh K, Streja E, Kovesdy CP et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010; 85: 991-1001.
13. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: analysis of the United States renal data system dialysis morbidity and mortality wave II study. Kidney Int 2004; 65: 597-605.
14. Chazot C, Gassia J-P, Di Benedetto A et al. Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant 2009; 24: 2871-2876.
15. Fleischmann E, Teal N, Dudley J et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567.
16. Johansen KL, Young B, Kaysen GA et al. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332.
17. Lu JL, Kalantar-Zadeh K, Ma JZ et al. Association of body mass index with outcomes in patients with CKD. J Am SocNephrol 2014; 25: 2088-2096.
18. Bashey S, Muntner P, Kini AS et al. Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention. Am J Cardiol 2011; 107: 1415-1420.
19. Hanks LJ, Tanner RM, Muntner P et al. Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol 2013; 8: 2064-2071.
20. Vivante A, Golan E, Tzur D et al. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med 2012; 172: 1644-55.
21. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for endstage renal disease. Ann Intern Med 2006; 144: 21-28.
22. Hsu C-y Iribarren C, McCulloch CE et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342.
23. Iseki K, Ikemiya Y, Fukiyama K. Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 1997; 63: S169-S170.
24. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876.
25. Reynolds K, Gu D, Muntner P et al. Body mass index and risk of ESRD in China. Am J Kidney Dis 2007; 50: 754-764.
26. Stenvinkel P, Heimbu? Rger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-960.
27. Yao Q, Lindholm B, Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 2004; 8: 118-129.
28. Balakrishnan VS, Guo D, Rao M et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004; 65: 1449-1460.
29. Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307.
30. Van Gaal LF, Mertens IL, Christophe E. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
31. Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 992-998.
32. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
33. Kitiyakara C, Yamwong S, Cheepudomwit S et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007; 71: 693-700.
34. Luk AO, So WY, Ma RC et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008; 31: 2357-2361.
35. Sun F, Tao Q, Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Nephrology 2010; 15: 84-92.
36. Chen J, Gu D, Chen CS et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007; 22: 1100-1106.
37. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
38. Cheng HT, Huang JW, Chiang CK et al. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab 2012; 97: 1268-1276.
39. Navaneethan SD, Schold JD, Kirwan JP et al. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol 2013; 8: 945-952.
40. Howard VJ, Cushman M, Pulley L et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005; 25: 135-143.
41. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
42. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Inter Med 2009; 150: 604-612.